|Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments|
EJS Sonuga-Barke, D Brandeis, S Cortese, D Daley, M Ferrin, ...
American Journal of Psychiatry 170 (3), 275-289, 2013
|European clinical guidelines for hyperkinetic disorder–first upgrade|
E Taylor, M Döpfner, J Sergeant, P Asherson, T Banaschewski, ...
European child & adolescent psychiatry 13 (1), i7-i30, 2004
|Long-acting medications for the hyperkinetic disorders|
T Banaschewski, D Coghill, P Santosh, A Zuddas, P Asherson, J Buitelaar, ...
European child & adolescent psychiatry 15 (8), 476-495, 2006
|Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology|
GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ...
Journal of Psychopharmacology 30 (6), 495-553, 2016
|The quality of life of children with attention deficit/hyperactivity disorder: a systematic review|
M Danckaerts, EJS Sonuga-Barke, T Banaschewski, J Buitelaar, ...
European child & adolescent psychiatry 19 (2), 83-105, 2010
|Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis|
A Cipriani, X Zhou, C Del Giovane, SE Hetrick, B Qin, C Whittington, ...
The Lancet 388 (10047), 881-890, 2016
|European guidelines on managing adverse effects of medication for ADHD|
J Graham, T Banaschewski, J Buitelaar, D Coghill, M Danckaerts, ...
European child & adolescent psychiatry 20 (1), 17-37, 2011
|Cognitive training for attention-deficit/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials|
S Cortese, M Ferrin, D Brandeis, J Buitelaar, D Daley, RW Dittmann, ...
Journal of the American Academy of Child & Adolescent Psychiatry 54 (3), 164-174, 2015
|Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines|
A Cleare, CM Pariante, AH Young, IM Anderson, D Christmas, PJ Cowen, ...
Journal of Psychopharmacology 29 (5), 459-525, 2015
|Molecular genetics of attention-deficit/hyperactivity disorder: an overview|
T Banaschewski, K Becker, S Scherag, B Franke, D Coghill
European child & adolescent psychiatry 19 (3), 237-257, 2010
|Behavioral interventions in attention-deficit/hyperactivity disorder: a meta-analysis of randomized controlled trials across multiple outcome domains|
D Daley, S Van der Oord, M Ferrin, M Danckaerts, M Doepfner, S Cortese, ...
Journal of the American Academy of Child & Adolescent Psychiatry 53 (8), 835 …, 2014
|Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents|
S Cortese, M Holtmann, T Banaschewski, J Buitelaar, D Coghill, ...
Journal of Child Psychology and Psychiatry 54 (3), 227-246, 2013
|Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta …|
S Cortese, N Adamo, C Del Giovane, C Mohr-Jensen, AJ Hayes, ...
The Lancet Psychiatry 5 (9), 727-738, 2018
|Annual research review: categories versus dimensions in the classification and conceptualisation of child and adolescent mental disorders–implications of recent empirical study|
D Coghill, EJS Sonuga‐Barke
Journal of Child Psychology and Psychiatry 53 (5), 469-489, 2012
|The validity, reliability and normative scores of the parent, teacher and self report versions of the Strengths and Difficulties Questionnaire in China|
Y Du, J Kou, D Coghill
Child and adolescent psychiatry and mental health 2 (1), 1-15, 2008
|ADHD in children and young people: prevalence, care pathways, and service provision|
K Sayal, V Prasad, D Daley, T Ford, D Coghill
The Lancet Psychiatry 5 (2), 175-186, 2018
|Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for …|
B Bolea-Alamañac, DJ Nutt, M Adamou, P Asherson, S Bazire, D Coghill, ...
Journal of psychopharmacology 28 (3), 179-203, 2014
|Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults|
S McCarthy, P Asherson, D Coghill, C Hollis, M Murray, L Potts, K Sayal, ...
The British Journal of Psychiatry 194 (3), 273-277, 2009
|Effects of methylphenidate on cognitive functions in children and adolescents with attention-deficit/hyperactivity disorder: evidence from a systematic review and a meta-analysis|
DR Coghill, S Seth, S Pedroso, T Usala, J Currie, A Gagliano
Biological psychiatry 76 (8), 603-615, 2014
|Influence of gender on attention-deficit/hyperactivity disorder in Europe–ADORE|
TS Nøvik, A Hervas, SJ Ralston, S Dalsgaard, RR Pereira, MJ Lorenzo
European child & adolescent psychiatry 15 (1), i15-i24, 2006